This new variant may have the potential to reduce vaccine efficacy. Whether it reduces efficacy     against severe disease and hospitalization is uncertain. A booster dose can provide around 75% protection against symptomatic infection from Omicron, a study has concluded. A booster dose would increase the number of antibodies in people which can help prevent severe infection.